An in-depth analysis on the effects of body composition in patients receiving neoadjuvant chemotherapy for urothelial cell carcinoma

CONCLUSIONS: Based on our retrospective cohort study, NAC did not affect obesity and FMI, but there was a significant decrease in SMI. Sarcopenic obesity was associated with increased severity of NAC adverse events. As such, the presence of this factor may help predict tolerance of NAC.PMID:38381924 | DOI:10.5489/cuaj.8542

Source: Canadian Urological Association Journal - February 21, 2024 Category: Urology & Nephrology Authors: Landan MacDonald Ricardo A Rendon Myuran Thana Lori Wood Robyn MacFarlane David Bell Jon Duplisea Ross Mason Source Type: research